Davis Smith W
Known title: DirectorCIK: 0001741178
Associated companies
Transaction History
| MLM | ▲ Buy | Grant | 94 | $34K | 2/28/2023 | View on chart |
| MLM | ▲ Buy | Grant | 93 | $34K | 11/30/2022 | View on chart |
| MLM | ▲ Buy | Grant | 98 | $34K | 8/31/2022 | View on chart |
| MLM | ▲ Buy | Grant | 100 | $34K | 5/31/2022 | View on chart |
| MLM | ▲ Buy | Grant | 443 | $0 | 5/12/2022 | View on chart |
| MLM | ▲ Buy | Grant | 89 | $34K | 2/28/2022 | View on chart |
| MLM | ▲ Buy | Grant | 84 | $34K | 11/30/2021 | View on chart |
| MLM | ▲ Buy | Grant | 89 | $34K | 8/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Martin Marietta Earnings Loom as JPMorgan Cuts Price Target
Investors are focused on Martin Marietta's upcoming earnings release. JPMorgan recently maintained an Overweight rating on the stock but lowered its price target to $650. This move provides context for the current valuation ahead of the company's financial results.
Martin Marietta Earnings Loom as JPMorgan Cuts Price Target. Investors are focused on Martin Marietta's upcoming earnings release. JPMorgan recently maintained an Overweight rating on the stock but lowered its price target to $650. This move provides context for the current valuation ahead of the company's financial results.